A new nested multi-time-scale stochastic approximation method eliminates ratio-induced bias in likelihood-free parameter ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A new perspective argues that a rich class of probability models known as Markov modulated models could transform how ...

I was thinking about a program to solve Sudoku.You fill a 9x9 grid with numbers from 1 to 9. The same number must not be ...

When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...

MONTREAL — The next advances in the capabilities of AI could well be made by AI itself, as tech giants and startups automate more machine learning research and development. Many firms are aiming for ...

Researchers from the National University of Singapore, A*STAR, and the Australian National University have demonstrated a ...

We introduce Multi-Agent Self-Supervision (MASS). One shared model solves tasks through a team of virtual subagents, searches for better multi-agent workflows, then uses its own judgments to select ...

OpenSSH 10.6 disables LZ77 compression, refuses some usernames and plans more frequent releases after AI-found bugs resurfaced.

Seller: Robert Hershberg, Director at Recursion Pharmaceuticals, Inc. Shares for sale: 25,000 Class A shares valued at ...

According to KyeGomezB, P Zero Research reports AI research taste doubled every 3 months since Dec 2025, surpassing expert baseline.

Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.